Aemetis (AMTX) Q2 2026 Earnings Call Transcript
Aemetis (AMTX) Q2 2026 earnings call said consolidated revenue rose 20% year over year, operating income improved by $16.4 million, and adjusted EBITDA increased by $15.5 million versus Q2 2025. The company cited CARB approval of 7 LCFS pathways and pending approvals for 6 digesters, plus ethanol projects including a $32 million annual cash flow MVR system. India biodiesel revenue was $2.5 million, with expected $17 million from new allocations.
How this was made
The 30-second read
Why it matters
Management attributes an earnings inflection to higher LCFS credit value from CARB-approved pathways (negative 380 vs negative 150 default) and expects additional revenue growth as pending pathways and a corrected DOE 45Z emissions rate are implemented. It also outlines ethanol cash-flow expansion from an MVR installation and corn oil separation upgrades, plus India biodiesel revenue tied to government allocations and private demand.
Market read
Traders can map the regulatory-credit timeline (CARB LCFS pathways and DOE 45Z emissions-rate correction) to forward revenue and cash-flow expectations, alongside quantified Q2 operating improvements.
What to watch
The call notes 45Z sold in July at a negative 42 emissions rate, implying current realized economics may lag the eventual methodology; also, India biodiesel revenue is subject to tender processing and delivery cadence.
Background
This is a Q2 2026 earnings call transcript covering RNG (dairy biogas digesters), California LCFS pathways, federal 45Z credits, ethanol projects, and India biodiesel allocations.
Ticker impact
Aemetis reports Q2 revenue +20% YoY, operating income +$16.4M, adjusted EBITDA +$15.5M, and details LCFS and 45Z timing catalysts.
Bias higher into the next approval milestones, but expect volatility around policy timing and any delays in DOE emissions-rate updates.
The call provides specific operational and policy-linked drivers (7 approved LCFS pathways, 6 pending, DOE 45Z emissions-rate correction expected in November) plus quantified Q2 improvements, which can re-rate forward cash flow expectations.
Market effects
Reinforces that RNG and low-carbon biofuels valuations are highly sensitive to LCFS pathway CI scores and 45Z emissions-rate methodology.
Highlights California CARB LCFS pathway approvals as a key determinant of RNG credit generation and revenue timing.
Limited direct global spillover, but underscores policy-driven economics in renewable fuels markets.
Counterpoint
Revenue uplift may be delayed or partially offset if DOE’s corrected 45Z emissions rate or CARB pathway approvals arrive later than expected, reducing near-term catch-up value.
Key entities
- companyAemetis
AMTX, reporting Q2 financial inflection and providing milestone timing for LCFS pathway approvals, DOE 45Z emissions-rate updates, ethanol capex projects, and India biodiesel deliveries.
